Non-invasive imaging of COX-2 expression with [18F]Pyricoxib in cancer would be useful for assessing COX-2-mediated effects on chemoprevention and radiosensitization using COX-2 inhibitors as an emerging class of anti-cancer drugs, especially for colorectal cancer. The gene discussed is PTGS2; the disease is colorectal cancer.